Elasomeran/tozinameranMyopericarditis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1965卷 / 1期

关键词：

D O I：

10.1007/s40278-023-43163-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：195 / 195

相关论文

共 50 条

[31] Elasomeran/tozinameranVitiligo and worsening of vitiligo : case report
Reactions Weekly, 2023, 1982 (1) : 179 - 179
[32] Elasomeran/TozinameranMyocarditis and pericarditis: 2 case report
Reactions Weekly, 2023, 1988 (1) : 66 - 66
[33] Elasomeran Immune-mediated myopathy: case report
Reactions Weekly, 2023, 1938 (1) : 566 - 566
[34] Elasomeran/tozinameranMultisystem inflammatory syndrome in children: case report
Reactions Weekly, 2022, 1897 (1) : 165 - 165
[35] Elasomeran/tozinameranUlcerative injection site reaction: case report
Reactions Weekly, 2023, 1941 (1) : 185 - 185
[36] Elasomeran/davesomeran/tozinameranAxillary lymphadenopathy and pericarditis: case report
Reactions Weekly, 2023, 1968 (1) : 135 - 135
[37] Elasomeran/tozinameranIdiopathic orbital inflammation and dacryoadenitis: case report
Reactions Weekly, 2023, 1944 (1) : 254 - 254
[38] Elasomeran/PrednisoneVarious toxicities and lack of efficacy: case report
Reactions Weekly, 2024, 2029 (1) : 252 - 252
[39] TozinameranMyopericarditis: 9 case reports
Reactions Weekly, 2023, 1986 (1) : 423 - 423
[40] Elasomeran/tozinameranType 1 lepra reaction: case report
Reactions Weekly, 2023, 1957 (1) : 228 - 228

← 1 2 3 4 5 →